This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Eklof, B. Articles by Masuda, E. M. Search for Related Content PubMed Articles by Eklof, B. Articles by Masuda, E. M. Social Bookmarking                         What's this?

Contemporary Treatment of Iliofemoral Deep Vein Thrombosis

John A. Burns School of Medicine, University of Hawaii, Straub Clinic and Hospital, Honolulu, HI

Curtis B. Kamida, M.D.

John A. Burns School of Medicine, University of Hawaii, Straub Clinic and Hospital, Honolulu, HI

Robert L. Kistner, M.D.

John A. Burns School of Medicine, University of Hawaii, Straub Clinic and Hospital, Honolulu, HI

Elna M. Masuda, M.D.

John A. Burns School of Medicine, University of Hawaii, Straub Clinic and Hospital, Honolulu, HI

The standard treatment for acute iliofemoral venous thrombosis has been hospital admission with bedrest, leg elevation, and anticoagulation using unfractionated heparin IV and warfarin. With the recent release from the FDA of low molecular weight heparin we can anticipate a rapid embrace of this drug for ambulatory treatment. Based on level I studies from mainly Canada and Europe, low molecular weight heparin has been proven to be highly effective in the initial treatment of established deep vein thrombosis. We will argue that the long term sequels of low molecular weight heparin treatment is not known. Early and quick removal of the thrombus is indicated to avoid the late postthrombotic syndrome. We suggest that catheter-directed intrathrombus thrombolysis with or without adjunct procedures such as angioplasty and stenting should be the first line of treatment. When there are contraindications or failure of thrombolysis, thrombectomy with a temporary arteriovenous fistula is a valid alternative, with both interventions followed by anticoagulation.

Key Words: Low molecular weight heparin • catheter-directed intrathrombus thrombolysis • thrombectomy with temporary arteriovenous fistula

Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 11, No. 1, 1-21 (1999)
DOI: 10.1177/153100359901100102


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?